N23 (Neggram 1 GM)
Generic Name: nalidixic acid
Pill with imprint N23 is Yellow, Elliptical / Oval and has been identified as Neggram 1 GM. It is supplied by Sanofi-Synthelabo Inc.
NegGram is used in the treatment of bladder infection; prevention of bladder infection and belongs to the drug classes quinolones, urinary anti-infectives. Risk cannot be ruled out during pregnancy. NegGram 1 GM is not a controlled substance under the Controlled Substances Act (CSA).
Images for N23
Neggram
- Generic Name:
- nalidixic acid
- Imprint:
- N23
- Strength:
- 1 GM
- Color:
- Yellow
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Quinolones
Urinary anti-infectives - Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Sanofi-Synthelabo Inc
- National Drug Code (NDC):
- 00024-1323
More about NegGram (nalidixic acid)
- NegGram Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- 0 Reviews – Add your own review/rating
- Drug class: quinolones
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
